Sun Pharma specialty drug Tildrakizumab makes it to China's reimbursement listThe inclusion of tildrakizumab injection in NRDL will further boost Sun Pharma commercialisation efforts globally. NRDL is a list of drugs ...
Mumbai builders see an opportunity in small homes despite rising prices and market uncertaintyDevelopers, who too stayed away from this segment due to lower margins, have sensed a change in mood and have spotted an opportunity.
Growth MoleculeDr Swati A Piramal, director, strategic alliances & communications of Nicholas Piramal India Ltd (NPIL), has her hands full.